Key Performance Indicators
Search documents
Redwire (RDW) - 2025 Q4 - Earnings Call Presentation
2026-02-26 14:00
INVESTOR UPDATE Q4 and FY25 FEBRUARY 26, 2026 USE OF DATA Industry and market data used in this Presentation have been obtained from third-party industry publications and sources, as well as from research reports prepared for other purposes. Redwire has not independently verified the data obtained from these sources and cannot assure you of the data's accuracy or completeness. This data is subject to change. Statements other than historical facts, including, but not limited to, those concerning market condi ...
GoHealth(GOCO) - 2025 Q3 - Earnings Call Presentation
2025-11-13 13:00
Financial Performance - Q3 2024 - Net revenues for Q3 2024 were $118.292 million, compared to $132.037 million in Q3 2023[28] - Net loss for Q3 2024 was $15.366 million, compared to a net income of $(56.204) million in Q3 2023[28] - Adjusted EBITDA for Q3 2024 was $(12.106) million, compared to $(11.475) million in Q3 2023[28] - Adjusted EBITDA margin for Q3 2024 was (10.2)%, compared to (8.7)% in Q3 2023[28] Financial Performance - YTD 2024 - Net revenues for the nine months ended September 30, 2024, were $409.762 million, compared to $457.974 million for the same period in 2023[28] - Net loss for the nine months ended September 30, 2024, was $(65.294) million, compared to $(148.976) million for the same period in 2023[28] - Adjusted EBITDA for the nine months ended September 30, 2024, was $2.480 million, compared to $18.091 million for the same period in 2023[28] - Adjusted EBITDA margin for the nine months ended September 30, 2024, was 0.6%, compared to 4.0% for the same period in 2023[28] Financial Performance - TTM - TTM net revenues as of Q3 2024 were $686.459 million, compared to $527.350 million as of Q3 2023[32] - TTM net loss as of Q3 2024 was $(67.588) million, compared to $(299.713) million as of Q3 2023[32] - TTM Adjusted EBITDA as of Q3 2024 was $59.480 million, compared to $(76.690) million as of Q3 2023[32] - TTM Adjusted EBITDA margin as of Q3 2024 was 8.7%, compared to (14.5)% as of Q3 2023[32]
Marex Group plc(MRX) - Prospectus
2024-10-15 20:45
Table of Contents As filed with the Securities and Exchange Commission on October 15, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Marex Group plc (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant's Name into English) England and Wales 6200 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industri ...
Marex Group plc(MRX) - Prospectus(update)
2024-04-15 13:14
Table of Contents As filed with the Securities and Exchange Commission on April 15, 2024. Registration No. 333-278231 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Marex Group plc (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant's Name into English) (State or Other Jurisdiction of Incorporation or Organization) England and Wales 6200 Not Applicable (Pr ...